Biocon Limited (NSE:BIOCON)

Biocon Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	526,753	584,070	408,948	315,392	246,192	399,173
Market Cap Growth	7.82%	42.82%	29.66%	28.11%	-38.32%	-17.63%
Enterprise Value	668,160	750,906	607,421	513,003	277,130	425,255
Last Close Price	330.30	360.47	340.84	263.12	204.36	331.82

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	96.08	151.47	40.36	30.85	53.21	61.56
Forward PE	67.13	61.80	56.28	34.10	21.39	35.74
PS Ratio	3.11	3.45	2.68	2.14	2.20	4.88
PB Ratio	1.47	1.60	1.48	1.25	1.10	4.22
P/TBV Ratio	10.30	11.18	-	-	-	5.61
P/FCF Ratio	274.26	297.84	21.25	24.77	95.98	-
P/OCF Ratio	26.97	29.29	10.07	10.68	13.29	33.93
PEG Ratio	1.09	1.07	1.57	1.19	0.59	1.20

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	3.92	4.44	3.98	3.48	2.48	5.20
EV/EBITDA Ratio	18.60	21.27	19.44	15.68	10.43	21.74
EV/EBIT Ratio	40.36	44.32	39.36	28.77	17.72	36.71
EV/FCF Ratio	346.37	382.92	31.56	40.29	108.04	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.42	0.42	0.66	0.64	0.80	0.54
Debt / EBITDA Ratio	4.23	4.29	5.77	4.91	6.73	2.61
Debt / FCF Ratio	-	78.71	9.54	12.78	70.25	-
Net Debt / Equity Ratio	0.32	0.32	0.50	0.54	0.64	0.23
Net Debt / EBITDA Ratio	3.22	3.27	4.42	4.19	5.38	1.12
Net Debt / FCF Ratio	-	58.90	7.17	10.76	55.72	-4.19
Asset Turnover	-	0.28	0.27	0.27	0.31	0.42
Inventory Turnover	-	1.21	1.22	1.22	1.29	1.52
Quick Ratio	-	0.71	0.71	0.58	0.87	1.43
Current Ratio	-	1.22	1.14	0.99	1.45	2.19
Return on Equity (ROE)	-	1.15%	5.39%	5.43%	4.02%	8.58%
Return on Assets (ROA)	-	1.73%	1.68%	2.06%	2.70%	3.72%
Return on Invested Capital (ROIC)	3.04%	3.11%	2.90%	4.01%	4.63%	8.49%
Return on Capital Employed (ROCE)	-	3.40%	3.50%	4.40%	3.60%	7.00%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	1.04%	0.66%	2.48%	3.24%	1.88%	1.62%
FCF Yield	0.36%	0.34%	4.71%	4.04%	1.04%	-1.31%
Dividend Yield	0.15%	0.14%	0.15%	0.19%	0.73%	0.15%
Payout Ratio	14.85%	17.35%	5.92%	19.85%	12.95%	-
Buyback Yield / Dilution	-22.59%	-14.22%	-0.11%	-0.08%	0.04%	0.03%
Total Shareholder Return	-22.44%	-14.08%	0.03%	0.11%	0.76%	0.18%

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error